The CMIC Group started business as a company supporting drug development, and it has since developed a broad range of businesses in addition to CRO services, thus developing a unique business model that we call “Pharmaceutical Value Creator(PVC).”  Through offering a variety of services, CMIC Group can obtain an extensive amount of valuable information promptly. Therefore, we don’t just seek to expand the scope of our business, but also aim to provide added value for our clients in the pharmaceutical industry.

We also offer services to medical device manufacturers, academia, bio-ventures, and medical institutions. We also provide prophylaxis and health enhancing services to the public.

Our focus is on pharmaceuticals, aiming through our various services to swiftly deliver safe and effective drugs to patients.

We will continue to establish business models that create further value and contribute to greater advances in the pharmaceutical industry.

Contract Research Organization (CRO)

Contract Development and Manufacturing (CDMO)

Contract Sales Organization (CSO)

Site Management Organization (SMO)

Japan Market Entry/Innovative Pharma Model (IPM)